Korea Bio-Gen Co.Ltd Financial Flexibility Index
Korea Bio-Gen Co.Ltd financial flexibility index. Korea Bio-Gen Co.Ltd (318000) has a Financial Flexibility Index of 0.25x as of June 2026. Free cash flow of ₩1.55 Billion (operating CF ₩1.51 Billion minus capex ₩40.03 Million) represents 0% of total liabilities (₩6.11 Billion). See 318000 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Korea Bio-Gen Co.Ltd (2017–2025)
Financial flexibility index of Korea Bio-Gen Co.Ltd from 2017 to 2025. Historical Financial Flexibility Index trend for Korea Bio-Gen Co.Ltd across 9 annual periods. Check Korea Bio-Gen Co.Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Korea Bio-Gen Co.Ltd Financial Flexibility Index by Year (2017–2025)
Korea Bio-Gen Co.Ltd financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for Korea Bio-Gen Co.Ltd. For the full cash flow conversion analysis, see Korea Bio-Gen Co.Ltd operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.44x | ₩7.80 Billion | ₩7.34 Billion | ₩5.42 Billion | ▲ +2.9% |
| 2024 | 1.40x | ₩9.41 Billion | ₩4.29 Billion | ₩6.73 Billion | ▼ -54.2% |
| 2023 | 3.05x | ₩11.89 Billion | ₩9.47 Billion | ₩3.90 Billion | ▲ +526.6% |
| 2022 | 0.49x | ₩3.96 Billion | ₩1.67 Billion | ₩8.13 Billion | ▼ -7.3% |
| 2021 | 0.52x | ₩5.45 Billion | ₩3.09 Billion | ₩10.39 Billion | ▼ -55.8% |
| 2020 | 1.19x | ₩3.45 Billion | ₩2.58 Billion | ₩2.91 Billion | ▼ -47.5% |
| 2019 | 2.26x | ₩5.60 Billion | ₩3.05 Billion | ₩2.47 Billion | ▲ +607.6% |
| 2018 | 0.32x | ₩2.83 Billion | ₩1.98 Billion | ₩8.83 Billion | ▲ +16.6% |
| 2017 | 0.27x | ₩2.16 Billion | ₩1.38 Billion | ₩7.88 Billion | — |